The Human Microbiome: from Sequencing to Therapeutics

Originally Aired: June 15, 2018


The human microbiome is emerging as a critical modulator of multiple aspects of host physiology and health. Changes in microbiome composition and behavior have now been associated with pathophysiological disorders in multiple organ systems. Importantly, a number of studies are beginning to reveal the potential of the microbiome and microbially synthesized—as well as derived—products in their ability to treat infection, inflammatory and autoimmune disease, and cancer, among other illnesses.

In this Cell Press webinar, Rob Knight (University of California, San Diego), Michael Fischbach (University of California, San Francisco), and Elaine Hsiao (University of California, Los Angeles) will explore how this field is forging ahead by integrating sequencing approaches with physiology and small-molecule therapeutics.

Presenter
Rob Knight
Professor, Department of Pediatrics; Professor, Department of Computer Science
University of California, San Diego
View Biography
Presenter
Michael Fischbach
Associate Professor, Department of Bioengineering
University of California, San Francisco
View Biography
Presenter
Elaine Hsiao
Assistant Professor, Department of Integrative Biology and Physiology
University of California, Los Angeles
View Biography
Presenter
Moderator:
Ella Hinson
Senior Editor, Cell Host & Microbe

Presenter
Moderator:
Sri Devi Narasimhan
Senior Editor, Cell

Registration Details:

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

(*) denotes required form field(s)

Submit